Isoflavones improve vascular reactivity in post-menopausal women with hypercholesterolemia

Vascular Medicine

Volumn 9, Issue 1, 2004, Pages 26-30

  Lissin, Lynette Wroblewski ^a   Oka, Roberta ^b   Lakshmi, Subbu ^a   Cooke, John P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Isoflavones; Phytoestrogen; Post menopausal; Vasodilation

Indexed keywords

ANTIOXIDANT; ARGININE; CALCIUM CHANNEL BLOCKING AGENT; DAIDZEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; GENISTEIN; GLYCERYL TRINITRATE; GLYCITEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOFLAVONE DERIVATIVE; NITRATE; NITRITE; NOVASOY; PHYTOESTROGEN; PLACEBO; SOYBEAN PROTEIN;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG RESPONSE; ENDOTHELIUM; ESTROGEN THERAPY; FEMALE; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; HYPERCHOLESTEROLEMIA; INFLAMMATION; LIPID BLOOD LEVEL; MORTALITY; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; URINE LEVEL; VASODILATATION;

AGED; BRACHIAL ARTERY; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; ISOFLAVONES; LIPIDS; MIDDLE AGED; POSTMENOPAUSE; VASODILATION;

EID: 3042771534     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1191/1358863x04vm531oa     Document Type: Article

References (47)

1. Kato H, Tillotson J, Nichaman MZ, Rhoads GG, Hamilton HB. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii, and California. Am J Epidemiol 1973; 97: 372-85.
2. Stamler J. Population studies. In: Levy RI, Rifkind BM, Dennis BH, Ernst N (eds). Nutrition lipids and coronary heart disease. New York: Raven Press, 1979: 25-88.
3. Nevala R, Korpela R, Vapaatalo H. Plant derived estrogens relax rat mesenteric artery in vitro. Life Sci 1998; 63: 95-100.
4. Honore EK, Williams JK, Anthony MS, Clarkson TB. Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril 1997; 67: 148-54.
5. Nestel PJ, Yamashita T, Sasahara T et al. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol 1997; 17: 3392-98.
6. Cooke JP. The endothelium: a new target for therapy. Vasc Med 2000; 5: 49-53.
7. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995; 332: 276-82.
8. Anthony MS, Clarkson TB, Hughes CL, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 1996; 126: 43-50.
9. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24: 1468-74.
10. Zhang Y, Wang GJ, Song TT, Murphy PA, Hendrich S. Urinary disposition of the soybean isoflavones daidzein, genistein and glycitein differs among humans with moderate fecal isoflavone degradation activity. J Nutr 1999; 129: 957-62.
11. Figtree GA, Griffiths H, Lu YQ et al. Plant-derived estrogens relax coronary arteries in vitro by a calcium antagonistic mechanism. J Am Coll Cardiol 2000; 35: 1977-85.
12. Anderson TJ, Elstein E, Haber H, Charbonneau F. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease. J Am Coll Cardiol 2000; 35: 60-66.
13. Verhaar MC, Honigh ML, van Dam T et al. Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids. Cardiovasc Res 1999; 42: 752-60.
14. Vogel RA, Corretti MC, Plotnick GD. Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men. Am J Cardiol 1996; 77: 37-40.
15. Simons LA, Sullivan D, Simons J, Celermajer DS. Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia. Atherosclerosis 1998; 137: 197-203.
16. Plotnick GD, Corretti MC, Vogel RA. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. JAMA 1997; 278: 1682-86.
17. Kugiyama K, Motoyama T, Doi H et al. Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels. J Am Coll Cardiol 1999; 33: 1512-18.
18. Lieberman EH, Gerhard MD, Uehata A et al. Estrogen improves endothelial-dependent flow mediated vasodilation in postmenopausal women. Ann Intern Med 1994; 121: 936-41.
19. Kapiotis S, Hermann M, Held I et al. Genistein, the dietary derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler Thromb Vasc Biol 1997; 17: 2868-74.
20. Tikkanen MJ, Wahala K, Ojala S et al. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci USA 1998; 95: 3106-10.
21. Wei H, Bowen R, Cai Q et al. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 1995; 208: 124-30.
22. Spurrell BE, Murphy TV, Hill MA. Tyrosine phosphorylation modulates arteriolar tone but is not fundamental to myogenic response. Am J Physiol Heart Circ Physiol 2000; 278: H373-82.
23. Zerrouk A, Auguet M, Dabire H, Brisac AM, Safar M, Chabrier PE. Differential effects of tyrosine kinase inhibitors on contraction and relaxation of the aortas of normotensive and hypertensive rats. Eur J Pharmacol 1999; 374: 49-58.
24. Duarte J, Ocete MA, Perez-Vizcaino F, Zarzuelo A, Tamargo J. Effect of tyrosine kinase and tyrosine phosphatase inhibitors on aortic contraction and induction of nitric oxide synthase. Eur J Pharmacol 1997; 338: 25-33.
25. Vostal JG, Shafer B. Thapsigargin-induced calcium-influx in the absence of detectable tyrosine phosphorylation in human platelets. J Biol Chem 1996; 271: 19 524-29.
26. Deodato B, Altavilla D, Squadrito G et al. Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury. Br J Pharmacol 1999; 128: 1683-90.
27. Ohta T, Yasuda W, Hasegawa A, Ito S, Nakazato Y. Effects of inhibitors for tyrosine kinase and non-selective cation channel on capacitative Ca 2 + entry in rat ileal smooth muscle. Eur J Pharmacol 2000; 387: 211-20.
28. Adlercruetz H, Goldin BR, Gorbach SL et al. Soybean phytoestrogen intake and cancer risk. J Nutr 1995; 125: 757S-70S.
29. Williams JD, Adams MR, Herrington DM, Clarkson TB. Short term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 1992; 20: 452-57.
30. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990; 81: 1680-87.
31. Reis SE, Gloth ST, Blumenthal RS et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994; 89: 52-60.
32. Gilligan DM, Quyyumi AA, Cannon RO. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994; 89: 2545-51.
33. Al-Khalili F, Eriksson M, Landgren B, Schenck-Gustafsson. Effect of conjugated estrogen on peripheral flow mediated vasodilation in postmenopausal women. Am J Cardiol 1998; 82: 215-18.
34. 2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol 1992; 106: 739-45.
35. 2 in porcine coronary artery. Circulation 1995; 91: 2619-26.
36. Sudhir K, Chou TM, Mullen WL et al. Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries. J Am Coll Cardiol 1995; 26: 807-14.
37. Fotsis T, Pepper M, Adlercreutz H et al. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 1995; 125: 790S-97S.
38. Peterson G, Barnes S. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptor and multi-drug resistance gene product. Biochem Biophys Res Commun 1991; 179: 661-67.
39. Zava DT, Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 1997; 27: 31-40.
40. Barnes S, Grubbs C, Setchell KDR, Carlson J. Soybeans inhibit mammary tumors in models of breast cancer. In: Pariza M (ed). Mutagens and carcinogens in the diet. New York: Wiley-Liss, 239-53.
41. Messina MJ, Persky V, Setchell KDR, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994; 21: 113-31.
42. Murkies AL, Lombard C, Strauss BJG. Dietary flour supplementation decreases postmenopausal hot flushes: effect of soy and wheat. Maturitas 1995; 21: 189-95.
43. Potter SM, Baum JA, Teng H et al. Soy protein and isoflavones. Their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998; 68 (6 suppl): 1375S-79S.
44. Arjmandi BH, Birnbaum RS, Juma S, Barengolts E, Kukreja SC. The synthetic phytoestrogen, ipriflavone, and estrogen prevent bone loss by different mechanisms. Calcif Tissue Int 2000; 66: 61-65.
45. Ishimi Y, Miyaura C, Ohmura M et al. Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology 1999; 140: 1893-900.
46. Simons LA, von Konigsmark M, Simons J, Celermajer DS. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am J Cardiol 2000; 85: 1297-301.
47. Anderson TJ, Uehata A, Gerhard MD et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235-41.